AstraZeneca Plc’s antibody cocktail was only 33% effective at preventing symptomatic Covid-19 in people who had been exposed to the virus, failing a study that was key to the drugmaker’s pandemic push.
Fuente: Youtube
AstraZeneca Plc’s antibody cocktail was only 33% effective at preventing symptomatic Covid-19 in people who had been exposed to the virus, failing a study that was key to the drugmaker’s pandemic push.
Fuente: Youtube
